ID PA2_APIME Reviewed; 167 AA. AC P00630; A5JGM7; Q8WPH5; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 25-OCT-2002, sequence version 3. DT 02-SEP-2026, entry version 185. DE RecName: Full=Phospholipase A2; DE Short=bvPLA2; DE EC=3.1.1.4; DE AltName: Full=Allergen Api m I; DE AltName: Full=Phosphatidylcholine 2-acylhydrolase; DE AltName: Allergen=Api m 1; DE Flags: Precursor; OS Apis mellifera (Honeybee). OC Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Altocrustacea; Allotriocarida; OC Hexapoda; Insecta; Pterygota; Neoptera; Eumetabola; Endopterygota; OC Hymenoptera; Apocrita; Aculeata; Apoidea; Anthophila; Apidae; Apis. OX NCBI_TaxID=7460; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Venom gland; RX PubMed=12167627; DOI=10.1074/jbc.m206647200; RA Moreira L.A., Ito J., Ghosh A., Devenport M., Zieler H., Abraham E.G., RA Crisanti A., Nolan T., Catteruccia F., Jacobs-Lorena M.; RT "Bee venom phospholipase inhibits malaria parasite development in RT transgenic mosquitoes."; RL J. Biol. Chem. 277:40839-40843(2002). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC TISSUE=Venom gland; RX PubMed=17466468; DOI=10.1016/j.gene.2007.03.007; RA Valdez-Cruz N.A., Segovia L., Corona M., Possani L.D.; RT "Sequence analysis and phylogenetic relationship of genes encoding RT heterodimeric phospholipases A2 from the venom of the scorpion Anuroctonus RT phaiodactylus."; RL Gene 396:149-158(2007). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 6-167. RC TISSUE=Venom gland; RX PubMed=2776767; DOI=10.1111/j.1432-1033.1989.tb15014.x; RA Kuchler K., Gmachl M., Sippl M.J., Kreil G.; RT "Analysis of the cDNA for phospholipase A2 from honeybee venom glands. The RT deduced amino acid sequence reveals homology to the corresponding RT vertebrate enzymes."; RL Eur. J. Biochem. 184:249-254(1989). RN [4] RP PROTEIN SEQUENCE OF 34-167. RC TISSUE=Venom; RX PubMed=4448181; DOI=10.1111/j.1432-1033.1974.tb03787.x; RA Shipolini R.A., Callewaert G.L., Cottrell R.C., Vernon C.A.; RT "The amino-acid sequence and carbohydrate content of phospholipase A2 from RT bee venom."; RL Eur. J. Biochem. 48:465-476(1974). RN [5] RP PROTEIN SEQUENCE OF 34-60, IDENTIFICATION BY MASS SPECTROMETRY, AND RP SEASONAL VARIATION. RX PubMed=20403370; DOI=10.1016/j.toxicon.2010.03.023; RA Ferreira Junior R.S., Sciani J.M., Marques-Porto R., Junior A.L., RA Orsi R.D., Barraviera B., Pimenta D.C.; RT "Africanized honey bee (Apis mellifera) venom profiling: Seasonal variation RT of melittin and phospholipase A(2) levels."; RL Toxicon 56:355-362(2010). RN [6] RP DISULFIDE BONDS. RX PubMed=4614976; DOI=10.1111/j.1432-1033.1974.tb03788.x; RA Shipolini R.A., Doonan S., Vernon C.A.; RT "The disulphide bridges of phospholipase A2 from bee venom."; RL Eur. J. Biochem. 48:477-483(1974). RN [7] RP GLYCOSYLATION AT ASN-46. RX PubMed=8504812; DOI=10.1111/j.1432-1033.1993.tb17870.x; RA Kubelka V., Altmann F., Staudacher E., Tretter V., Marz L., Hard K., RA Kamerling J.P., Vliegenthart J.F.; RT "Primary structures of the N-linked carbohydrate chains from honeybee venom RT phospholipase A2."; RL Eur. J. Biochem. 213:1193-1204(1993). RN [8] RP FUNCTION, AND BIOASSAY. RC TISSUE=Venom; RX PubMed=36550366; DOI=10.1038/s41598-022-26867-8; RA Shi N., Szanto T.G., He J., Schroeder C.I., Walker A.A., Deuis J.R., RA Vetter I., Panyi G., King G.F., Robinson S.D.; RT "Venom composition and pain-causing toxins of the Australian great RT carpenter bee Xylocopa aruana."; RL Sci. Rep. 12:22168-22168(2022). RN [9] RP X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 34-167 IN COMPLEX WITH CALCIUM RP ION, COFACTOR, AND DISULFIDE BONDS. RX PubMed=2274788; DOI=10.1126/science.2274788; RA Scott D.L., Otwinowski Z., Gelb M.H., Sigler P.B.; RT "Crystal structure of bee-venom phospholipase A2 in a complex with a RT transition-state analogue."; RL Science 250:1563-1566(1990). CC -!- FUNCTION: In vivo, intraplantar injection in mice cause spontaneous CC pain behaviors and paw swelling (PubMed:36550366). PLA2 catalyzes the CC calcium-dependent hydrolysis of the 2-acyl groups in 3-sn- CC phosphoglycerides. {ECO:0000269|PubMed:36550366}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn- CC glycero-3-phosphocholine + a fatty acid + H(+); Xref=Rhea:RHEA:15801, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868, CC ChEBI:CHEBI:57643, ChEBI:CHEBI:58168; EC=3.1.1.4; CC Evidence={ECO:0000255|PROSITE-ProRule:PRU10035}; CC -!- COFACTOR: CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108; CC Evidence={ECO:0000305|PubMed:2274788}; CC Note=Binds 1 Ca(2+) ion. {ECO:0000305|PubMed:2274788}; CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- TISSUE SPECIFICITY: Expressed by the venom gland. CC -!- PTM: N-glycosylated; contains mannose, N-acetylglucosamine and fucose CC alphal-6 and/or alphal-3 linked to the innermost N-acetylglucosamine. CC {ECO:0000269|PubMed:8504812}. CC -!- ALLERGEN: Causes an allergic reaction in human. CC -!- MISCELLANEOUS: The secretion of this protein into venom follows a CC seasonal pattern. This variation is synchronized with melittin CC variation, i.e. their production increase in the same months. CC -!- SIMILARITY: Belongs to the phospholipase A2 family. Group III CC subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF438408; AAL30844.1; -; mRNA. DR EMBL; EF373554; ABQ28728.1; -; Genomic_DNA. DR EMBL; X16709; CAA34681.1; -; mRNA. DR PIR; S05650; PSHBA. DR RefSeq; NP_001011614.1; NM_001011614.1. DR PDB; 1POC; X-ray; 2.00 A; A=34-167. DR PDB; 8PIH; X-ray; 1.76 A; A=35-167. DR PDB; 8PKC; X-ray; 4.10 A; A/B=34-167. DR AlphaFoldDB; P00630; -. DR SMR; P00630; -. DR FunCoup; P00630; 57. DR STRING; 7460.P00630; -. DR BindingDB; P00630; -. DR ChEMBL; CHEMBL4807; -. DR Allergome; 2493; Api m A1-A2. DR Allergome; 2778; Api m A1-A2-A3. DR Allergome; 3088; Api m 1.0101. DR Allergome; 45; Api m 1. DR GlyConnect; P00630; 16 N-Linked glycans (1 site). DR PaxDb; 7460-P00630; -. DR ABCD; P00630; 2 sequenced antibodies. DR EnsemblMetazoa; NM_001011614; NP_001011614; GeneID_406141. DR GeneID; 406141; -. DR KEGG; ame:406141; -. DR CTD; 124432273; -. DR eggNOG; ENOG502S1MS; Eukaryota. DR HOGENOM; CLU_118255_0_0_1; -. DR InParanoid; P00630; -. DR OMA; TTGCKEY; -. DR OrthoDB; 10059604at2759; -. DR PhylomeDB; P00630; -. DR BRENDA; 3.1.1.4; 387. DR EvolutionaryTrace; P00630; -. DR PRO; PR:P00630; -. DR Proteomes; UP000005203; Linkage group LG13. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0004623; F:A2-type glycerophospholipase activity; IEA:UniProtKB-EC. DR GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB. DR GO; GO:0050482; P:arachidonate secretion; IEA:InterPro. DR GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro. DR CDD; cd04704; PLA2_bee_venom_like; 1. DR FunFam; 1.20.90.10:FF:000002; Phospholipase A2 group III; 1. DR Gene3D; 1.20.90.10; Phospholipase A2 domain; 1. DR InterPro; IPR016090; PLA2-like_dom. DR InterPro; IPR033113; PLA2_histidine. DR InterPro; IPR036444; PLipase_A2_dom_sf. DR PANTHER; PTHR12253; RH14732P; 1. DR Pfam; PF05826; Phospholip_A2_2; 1. DR SMART; SM00085; PA2c; 1. DR SUPFAM; SSF48619; Phospholipase A2, PLA2; 1. DR PROSITE; PS00118; PA2_HIS; 1. DR PDBsum; 1POC; -. DR PDBsum; 8PIH; -. DR PDBsum; 8PKC; -. PE 1: Evidence at protein level; KW 3D-structure; Allergen; Calcium; Direct protein sequencing; Disulfide bond; KW Glycoprotein; Hydrolase; Lipid degradation; Lipid metabolism; KW Metal-binding; Reference proteome; Secreted; Signal. FT SIGNAL 1..18 FT /evidence="ECO:0000255" FT PROPEP 19..33 FT /evidence="ECO:0000269|PubMed:20403370, FT ECO:0000269|PubMed:4448181" FT /id="PRO_0000022982" FT CHAIN 34..167 FT /note="Phospholipase A2" FT /evidence="ECO:0000269|PubMed:2274788" FT /id="PRO_0000022983" FT ACT_SITE 67 FT /evidence="ECO:0000305|PubMed:2274788" FT ACT_SITE 97 FT /evidence="ECO:0000305|PubMed:2274788" FT BINDING 41 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000269|PubMed:2274788, FT ECO:0007744|PDB:1POC" FT BINDING 43 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000269|PubMed:2274788, FT ECO:0007744|PDB:1POC" FT BINDING 45 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000269|PubMed:2274788, FT ECO:0007744|PDB:1POC" FT BINDING 68 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000269|PubMed:2274788, FT ECO:0007744|PDB:1POC" FT CARBOHYD 46 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:8504812" FT /id="CAR_000001" FT DISULFID 42..64 FT /evidence="ECO:0000269|PubMed:2274788, FT ECO:0000269|PubMed:4614976" FT DISULFID 63..103 FT /evidence="ECO:0000269|PubMed:2274788, FT ECO:0000269|PubMed:4614976" FT DISULFID 70..96 FT /evidence="ECO:0000269|PubMed:2274788, FT ECO:0000269|PubMed:4614976" FT DISULFID 94..128 FT /evidence="ECO:0000269|PubMed:2274788, FT ECO:0000269|PubMed:4614976" FT DISULFID 138..146 FT /evidence="ECO:0000269|PubMed:2274788, FT ECO:0000269|PubMed:4614976" FT CONFLICT 72 FT /note="D -> N (in Ref. 4; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 85 FT /note="N -> D (in Ref. 4; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 89..90 FT /note="Missing (in Ref. 4; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 95..99 FT /note="DCDDK -> NNND (in Ref. 4; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 102..104 FT /note="Missing (in Ref. 4; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 125 FT /note="D -> N (in Ref. 4; AA sequence)" FT /evidence="ECO:0000305" FT TURN 40..42 FT /evidence="ECO:0007829|PDB:8PIH" FT HELIX 59..68 FT /evidence="ECO:0007829|PDB:8PIH" FT STRAND 71..74 FT /evidence="ECO:0007829|PDB:1POC" FT STRAND 87..89 FT /evidence="ECO:0007829|PDB:8PIH" FT STRAND 91..93 FT /evidence="ECO:0007829|PDB:8PIH" FT HELIX 94..106 FT /evidence="ECO:0007829|PDB:8PIH" FT HELIX 110..121 FT /evidence="ECO:0007829|PDB:8PIH" FT STRAND 127..133 FT /evidence="ECO:0007829|PDB:8PIH" FT STRAND 135..142 FT /evidence="ECO:0007829|PDB:8PIH" FT STRAND 145..151 FT /evidence="ECO:0007829|PDB:8PIH" FT STRAND 158..164 FT /evidence="ECO:0007829|PDB:8PIH" SQ SEQUENCE 167 AA; 19058 MW; 88D5086A0E47DCC1 CRC64; MQVVLGSLFL LLLSTSHGWQ IRDRIGDNEL EERIIYPGTL WCGHGNKSSG PNELGRFKHT DACCRTHDMC PDVMSAGESK HGLTNTASHT RLSCDCDDKF YDCLKNSADT ISSYFVGKMY FNLIDTKCYK LEHPVTGCGE RTEGRCLHYT VDKSKPKVYQ WFDLRKY //